Health Cor Management, L.P. Bluebird Bio, Inc. Transaction History

Health Cor Management, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$3.75 - $7.39 $1.71 Million - $3.36 Million	455,000 New	455,000 $2.88 Million
Q3 2020 Nov 16, 2020	SELL	$34.44 - $43.75 $8.98 Million - $11.4 Million	-260,700 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$27.12 - $45.97 $9.8 Million - $16.6 Million	-361,510 Reduced 58.1%	260,700 $15.9 Million
Q1 2020 May 15, 2020	SELL	$26.16 - $63.5 $1.52 Million - $3.7 Million	-58,220 Reduced 8.56%	622,210 $28.6 Million
Q4 2019 Feb 14, 2020	BUY	$46.96 - $61.67 $8.14 Million - $10.7 Million	173,340 Added 34.18%	680,430 $59.7 Million
Q3 2019 Nov 14, 2019	BUY	$59.47 - $93.1 $8.27 Million - $12.9 Million	139,000 Added 37.76%	507,090 $46.6 Million
Q2 2019 Aug 14, 2019	BUY	$75.84 - $105.21 $4.94 Million - $6.86 Million	65,200 Added 21.53%	368,090 $46.8 Million
Q1 2019 May 15, 2019	BUY	$64.44 - $104.11 $19.5 Million - $31.5 Million	302,890 New	302,890 $47.7 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $27M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Health Cor Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Health Cor Management, L.P. with notifications on news.